SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial ...

Ultraviolet light therapy may help reduce inflammation and disease severity in people with MS, according to data from a small ...

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...

Roche (OTCQX:RHHBY) shares closed ~4% higher in Europe on Monday as the maker of Ocrevus multiple sclerosis therapy announced ...

A medication used to treat MS also has a beneficial effect on the composition of the intestinal flora, according to researchers. Conversely, the gut flora also plays a role in which side effects occur ...

Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.

CAR T-cell therapy uses re-engineered immune cells to attack diseases. After proving its effectiveness on cancer patients, it is now being explored as a treatment for autoimmune diseases like multiple ...

Cognitive behavioral therapy and the mild stimulant modafinil both reduce fatigue in people with multiple sclerosis by about the same amount, finds a new study. Combining talk therapy and medication ...

At the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Stephen ...

Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...

Advances being used to treat cancer are now being applied to lupus, rheumatoid arthritis, and other disorders.